** Shares of biotech co Ginkgo Bioworks DNA.N fall 4% to $9.9
** Co late on Tuesday forecast 2025 revenue to be $160 mln to $180 mln, lower than analyst estimates of $189 mln as per data compiled by LSEG
** DNA reported Q4 net loss of $107.5 mln, vs analyst estimates of $80.1 mln
** Co reported Q4 revenue of $44 mln, vs analyst estimates of $44.5 mln
** Stock has fallen 82.4% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。